BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2207457)

  • 1. Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies.
    Kier P; Penner E; Bakos S; Kalhs P; Lechner K; Volc-Platzer B; Wesierska-Gadek J; Sauermann G; Gadner H; Emminger-Schmidmeier W
    Bone Marrow Transplant; 1990 Aug; 6(2):93-6. PubMed ID: 2207457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies after bone marrow transplantation in children with genetic disorders: relation to chronic graft-versus-host disease.
    Lortan JE; Rochfort NC; el-Tumi M; Vellodi A
    Bone Marrow Transplant; 1992 May; 9(5):325-30. PubMed ID: 1617316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation.
    Quaranta S; Shulman H; Ahmed A; Shoenfeld Y; Peter J; McDonald GB; Van de Water J; Coppel R; Ostlund C; Worman HJ; Rizzetto M; Tsuneyama K; Nakanuma Y; Ansari A; Locatelli F; Paganin S; Rosina F; Manns M; Gershwin ME
    Clin Immunol; 1999 Apr; 91(1):106-16. PubMed ID: 10219261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association.
    Bell SA; Faust H; Mittermüller J; Kolb HJ; Meurer M
    Br J Dermatol; 1996 May; 134(5):848-54. PubMed ID: 8736324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimitochondrial antibodies in patients with chronic graft-versus-host disease.
    Siegert W; Stemerowicz R; Hopf U
    Bone Marrow Transplant; 1992 Sep; 10(3):221-7. PubMed ID: 1422476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-mitosin antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Muro Y; Kamimoto T; Hagiwara M
    Bone Marrow Transplant; 1997 May; 19(9):951-3. PubMed ID: 9156273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery.
    Patriarca F; Skert C; Sperotto A; Zaja F; Falleti E; Mestroni R; Kikic F; Calistri E; Filì C; Geromin A; Cerno M; Fanin R
    Exp Hematol; 2006 Mar; 34(3):389-96. PubMed ID: 16543073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
    Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Imai K; Hashino S; Higa T; Sakurada K; Miyazaki T
    Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
    Przepiorka D; Chan KW; Champlin RE; Culbert SJ; Petropoulos D; Ippoliti C; Khouri I; Huh YO; Vreisendorp H; Deisseroth AB
    Bone Marrow Transplant; 1995 Dec; 16(6):737-41. PubMed ID: 8750262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.
    Ochs LA; Miller WJ; Filipovich AH; Haake RJ; McGlave PB; Blazar BR; Ramsay NK; Kersey JH; Weisdorf DJ
    Bone Marrow Transplant; 1994 Apr; 13(4):455-60. PubMed ID: 8019471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Martin SJ; Audrain MA; Oksman F; Ecoiffier M; Attal M; Milpied N; Esnault VL
    Bone Marrow Transplant; 1997 Jul; 20(1):45-8. PubMed ID: 9232255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant herpes virus serology and chronic graft-versus-host disease.
    Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
    Bone Marrow Transplant; 1989 Sep; 4(5):547-52. PubMed ID: 2551436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
    Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
    Bone Marrow Transplant; 1998 Oct; 22(8):755-61. PubMed ID: 9827972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation.
    Wechalekar A; Cranfield T; Sinclair D; Ganzckowski M
    Clin Lab Haematol; 2005 Aug; 27(4):247-9. PubMed ID: 16048492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
    Chan GW; Gorgun G; Miller KB; Foss FM
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
    Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
    Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody analysis of patients with graft versus host disease.
    Lister J; Messner H; Keystone E; Miller R; Fritzler MJ
    J Clin Lab Immunol; 1987 Sep; 24(1):19-23. PubMed ID: 3316659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.